M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery PharmaTimesNew alliance aims to accelerate development of future medicinesRead full story pharminent August 17, 2026 (Last updated: August 18, 2026) PharmaTimes New alliance aims to accelerate development of future medicines Read full story Post navigation Previous: Sandoz targets industry patent void with $322m Henlius dealNext: AstraZeneca Claims Dual Lung Cancer Phase 3 Wins, but Bispecific Failure Steals the Headline Related Stories M&A / Deals Sandoz targets industry patent void with $322m Henlius deal pharminent August 17, 2026 M&A / Deals PTC takes a chance on Sangamo’s Fabry disease gene therapy pharminent August 13, 2026 M&A / Deals Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset pharminent August 12, 2026
